# COMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHLOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE

> **NCT07652801** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Child Health Sciences and Children's Hospital, Lahore** · enrollment: 80 (estimated)

## Conditions studied

- HIE - Hypoxic - Ischemic Encephalopathy

## Interventions

- **DRUG:** MgSO4 (seizure prevention)
- **DRUG:** Melatonin , Mgso4

## Key facts

- **NCT ID:** NCT07652801
- **Lead sponsor:** University of Child Health Sciences and Children's Hospital, Lahore
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652801, "COMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHLOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*